• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Pediatrics

Lowering public insurance income limits shifts costs to families and hospitals

byMatthew Lin, MDandMarc Succi, MD
July 24, 2018
in Pediatrics, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Simulations that lowered the public insurance eligibility to 300%, 200% and 100% of the federal poverty line (FPL) resulted in a sizeable and increasing number of theoretically uncovered hospitalizations that may total up to $4.5B in health care costs.

2. Hospitalized children on public insurance who would become ineligible for public insurance based on lower the public insurance income limit were predominantly white, newborn and urban-based.

Evidence Rating Level: 2 (Good)    

Study Rundown: Medicaid and the Children’s Health Insurance Program (CHIP) provide health care coverage to over 30 million children. Both organizations are jointly funded by the federal government and state governments, with states largely administering the various components of their programs. Cuts to federal funding may force states to enact cost-saving strategies, including decreasing income eligibility thresholds for public insurance enrollment. The purpose of this study was to determine the number, estimated costs, and demographic characteristics of hospitalizations that would become ineligible for reimbursement under public insurance in 3 FPL limit eligibility scenarios. In such scenarios, reducing public insurance eligibility to 300%, 200% and 100% of the FPL resulted in up to 45.5-90.6% hospitalizations that would be uncovered by public insurance, totaling up to $1.2-4.5B in estimated costs that would be primarily displaced to families, other insurers or hospitals. The children covered by public insurance who would become ineligible for public insurance based on the 3 FPL limit eligibility scenarios were predominantly newborns, white and urban-based. Limitations of this study included data from only 14 states, use of zip codes as a proxy for socioeconomic status and inability to account for retained insurance coverage through disability status.

Click to read the study in Pediatrics

Relevant Reading: The impact of the Medicaid/CHIP expansions on children: a synthesis of the evidence

In-Depth [retrospective cohort]: Data was obtained from the Agency for Healthcare Research and Quality’s State Inpatient Databases (SID) for pediatric (<18 years of age) hospitalizations between January 1, 2014 and December 31, 2014. Zip codes were used as geocode proxies for FPL determination. States that did not provide zip codes in SID were excluded. A total of 775,460 hospitalizations from 14 states were included in the final analysis. The primary outcome included estimated number and cost of hospitalizations deemed ineligible for public reimbursement when public insurance eligibility thresholds were decreased to 300%, 200% and 100% of the FPL for publicly insured children. Secondary outcomes included demographic characteristics of publicly insured children who would lose eligibility under the above scenarios. Of the included families, approximately 43.1%, 27.2% and 11.2% lived below 300%, 200% and 100% of the FPL, respectively. Reducing the public insurance threshold to 300% of the FPL in 7/14 states where public insurance eligibility exceeds 300% of the FPL resulted in 155,000 uncovered hospitalizations, totaling $1.2B in estimated costs. Reducing public insurance threshold to 200% of the FPL in 13/14 states where public insurance eligibility exceeded 200% of the FPL resulted in 440,000 uncovered hospitalizations, totaling $3.1B in estimated costs. All states had public insurance thresholds exceeding 100% of the FPL and lowering this threshold to 100% resulted in 650,000 uncovered hospitalizations totaling $45.5B in estimated costs. White children (38%) comprised the largest percent of public insured hospitalized children in this study, followed by Hispanic (24.5%) and African American (20.2%) children. The majority of children resided in urban settings (84.2%) compared to rural (15.8%). Newborns represented the majority of children for all public insurance hospitalizations (53.2%).

RELATED REPORTS

#VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis

Medical cannabis provides little improvement to sleep in chronic pain patients

Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Previous Post

Mean platelet counts shown to decrease during pregnancy

Next Post

2 Minute Medicine Rewind July 23, 2018

RelatedReports

#VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis
StudyGraphics

#VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis

May 27, 2022
Parental cannabis use increasing, cigarette use decreasing
Chronic Disease

Medical cannabis provides little improvement to sleep in chronic pain patients

May 27, 2022
Genetic risk assessment for Alzheimer’s disease does not increase anxiety, depression or stress
Chronic Disease

Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms

May 26, 2022
#VisualAbstract: Ruxolitinib shows long-term safety and efficacy in inadequately controlled polycythaemia vera without splenomegaly
StudyGraphics

#VisualAbstract: Ruxolitinib shows long-term safety and efficacy in inadequately controlled polycythaemia vera without splenomegaly

May 26, 2022
Next Post

2 Minute Medicine Rewind July 23, 2018

UTI associated with increased risk of preeclampsia

Extreme preterm birth linked to hypertension at school age

UK primary care physicians frequently prescribing antipsychotics for non-psychotic disorders

Viral vector based gene therapies show promise for treating focal epilepsy [PreClinical]

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis
  • Medical cannabis provides little improvement to sleep in chronic pain patients
  • Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.